Upgrade to SI Premium - Free Trial

Ligand Pharma (LGND) PT Raised to $250 at BofA Securities

April 14, 2026 9:11 AM
BofA Securities analyst Jason Zemansky ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles